Alpine Immune Sciences Inc (DELISTED) (ALPN:DL)
65.00
USD |
NASDAQ |
May 17, 16:00
Alpine Immune Sciences Enterprise Value: 4.151B for May 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 111.16B |
| Climb Bio, Inc. | 173.46M |
| Regeneron Pharmaceuticals, Inc. | 73.36B |
| Vera Therapeutics, Inc. | 2.726B |
| Hyperion DeFi, Inc. | 25.21M |
Enterprise Value Related Metrics
| Profit Margin (Quarterly) | -254.8% |
| Earnings Yield | -0.99% |
| Normalized Earnings Yield | -0.9851 |